Luminal B breast cancer (ER+; PR+; HER2+) is supported by a proliferative stimulus triggered not only by the activation of the ER pathway but also by the stimulation of the HER2-mediated signaling pathway [36]. Here, ERBB2 is linked to breast cancer.